Albemarle（纽约证券交易所代码：ALB）在收益强劲后上涨4.3％|SEC_新浪财经

Albemarle Co. (NYSE:ALB – Get Rating) traded up 4.3% during mid-day trading on Thursday following a better than expected earnings announcement. The stock traded as high as $284.74 and last traded at $284.52. 687,009 shares traded hands during trading, a decline of 51% from the average session volume of 1,393,197 shares. The stock had previously closed at $272.79.

The specialty chemicals company reported $8.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $8.46 by $0.16. The company had revenue of $2.62 billion during the quarter, compared to analysts' expectations of $2.60 billion. Albemarle had a net margin of 27.77% and a return on equity of 26.84%. The firm's revenue was up 193.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.01 EPS.

Get

Albemarle

alerts:

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Credit Suisse Group lifted their price objective on shares of Albemarle from $200.00 to $240.00 and gave the company an "underperform" rating in a research report on Tuesday, January 31st. Oppenheimer increased their price target on shares of Albemarle from $461.00 to $497.00 and gave the company an "outperform" rating in a research report on Wednesday, January 25th. UBS Group cut their price objective on shares of Albemarle from $297.00 to $250.00 and set a "neutral" rating on the stock in a report on Wednesday, January 11th. Piper Sandler initiated coverage on Albemarle in a research report on Wednesday, January 25th. They issued an "overweight" rating and a $310.00 price objective on the stock. Finally, Piper Jaffray Companies began coverage on Albemarle in a research report on Thursday, January 26th. They set an "overweight" rating on the stock. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $299.37.

Insider Buying and Selling at Albemarle

In other news, CFO Scott Tozier sold 1,719 shares of Albemarle stock in a transaction on Friday, January 6th. The shares were sold at an average price of $220.00, for a total transaction of $378,180.00. Following the transaction, the chief financial officer now owns 63,384 shares in the company, valued at $13,944,480. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other Albemarle news, CFO Scott Tozier sold 1,719 shares of the business's stock in a transaction dated Friday, January 6th. The shares were sold at an average price of $220.00, for a total value of $378,180.00. Following the transaction, the chief financial officer now directly owns 63,384 shares in the company, valued at $13,944,480. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Karen G. Narwold sold 2,250 shares of the company's stock in a transaction that occurred on Thursday, December 1st. The shares were sold at an average price of $280.25, for a total transaction of $630,562.50. Following the sale, the executive vice president now owns 6,257 shares in the company, valued at $1,753,524.25. The disclosure for this sale can be found here. Insiders own 0.25% of the company's stock.

Institutional Trading of Albemarle

A number of institutional investors and hedge funds have recently bought and sold shares of ALB. SJS Investment Consulting Inc. bought a new stake in shares of Albemarle during the third quarter valued at approximately $28,000. Covestor Ltd increased its holdings in shares of Albemarle by 51.2% during the first quarter. Covestor Ltd now owns 130 shares of the specialty chemicals company's stock valued at $29,000 after acquiring an additional 44 shares in the last quarter. Tompkins Financial Corp increased its holdings in shares of Albemarle by 50.0% during the fourth quarter. Tompkins Financial Corp now owns 150 shares of the specialty chemicals company's stock valued at $33,000 after acquiring an additional 50 shares in the last quarter. McIlrath & Eck LLC increased its holdings in Albemarle by 39.0% in the 4th quarter. McIlrath & Eck LLC now owns 164 shares of the specialty chemicals company's stock worth $36,000 after buying an additional 46 shares during the period. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of Albemarle during the 3rd quarter worth approximately $37,000. 82.24% of the stock is currently owned by institutional investors.

Albemarle Stock Up 4.7 %

The firm has a market capitalization of $33.46 billion, a price-to-earnings ratio of 12.52, a P/E/G ratio of 0.60 and a beta of 1.58. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.08 and a current ratio of 1.73. The business has a 50 day simple moving average of $249.25 and a 200-day simple moving average of $265.98.

Albemarle Company Profile

(Get Rating)

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine, Catalysts, and All Other.